None listed
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Person from 19 to 80 years old 2. Patients with suspected vaginitis 3. Those who voluntarily decide to participate in this clinical study and are willing to comply with the clinical research protocol
Exclusion criteria
Exclusion criteria: 1. Those who have a history of adverse reactions to standard treatment drugs 2. Those who are suspected of uterine adnexitis, endometritis, or pelvic inflammatory disease 3. Those who have an intrauterine device 4. Those who are pregnant 5. Other cases where participation in this clinical study is deemed unsuitable at the discretion of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Nugent score | — |
Secondary
| Measure | Time frame |
|---|---|
| The percentage of participants with reduced detection of STI pathogens as a result of PCR testing in each group;The percentage of participants with reduced Nugent score in each group;The percentage of participants with reduced Nugent score in each group;The percentage of participants with improved vaginal pH;The percentage of participants with improved vaginal pH;Rate of change in symptom questionnaire scores in each group (individual items and 10 cm Visual Analog Scale);Rate of change in symptom questionnaire scores in each group (individual items and 10 cm Visual Analog Scale);Participant satisfaction in each group;Overall symptom improvement in each group (evaluated by participants);Nugent score in study group;Vaginal pH in study group;Symptom questionnaire scores in study group;Adverse events / Serious adverse events | — |
Countries
Korea, Republic of
Contacts
Hanyang University